BEAT News and Press, Heartbeam Inc. From 02/21/19

BioTelemetry, Inc. (BEAT) Q4 2018 Results Earnings Conference Call February 21, 2019, 05:00 PM ET Company Participants Joseph Capper - President & CEO Heather Getz - CFO Conference Call Participants Bruce Nudell - SunTrust Brooks O'Neil - Lake Street Capital Marco Rod...

BioTelemetry (NASDAQ: BEAT ): Q4 Non-GAAP EPS of $0.56 beats by $0.13 ; GAAP EPS of $0.29 in-line. More news on: BioTelemetry, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

MALVERN, Pa., Feb. 21, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the fourth quarter ended December 31, ...

MALVERN, Pa., Feb. 11, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its fourth quarter 2018 earnings on Thursday, February 21 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Thursday, February 21, 2019.&#...

NEW YORK, Jan. 29, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Dollar General Corporation (NYSE:DG), Zayo Group Holdings, Inc. (NYSE:ZAY...

MALVERN, Pa., Jan. 28, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, and Geneva Healthcare, Inc. (“Geneva”)...

BioTelemetry ( BEAT ) is a top acquisition target going into the new year. The company is the leading wireless medical device provider expanding on a booming niche, the mobile cardiac telemetry market. General cardiac monitoring is projected to exceed $30 billion within three years. At a mar...

MALVERN, Pa., Nov. 07, 2018 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) announced today that Stephan Rietiker has been elected to BioTelemetry’s Board of Directors. Dr. Rietiker was most recently the Chief Executive Officer of LifeWatch AG, until it was acquired by BioTel...

NEW YORK, Nov. 02, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of FleetCor Technologies, Inc. (NYSE:FLT), Materion Corporation (NYSE:MTR...

BioTelemetry ( BEAT +15.2% ) is up on almost double normal volume after posting Q3 results after the close yesterday. Highlights: More news on: BioTelemetry, Inc., Healthcare stocks news, Stocks on the move, Earnings news and commentary, Read more ...